General Information of This Metabolic Reaction (MR) (ID:
MR002224) |
Formula |
Reactant |
Secnidazole |
Product |
Hydroxymethyl metabolite of secnidazole |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Oxidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
In vitro metabolic profile and drug-drug interaction assessment of secnidazole, a high-dose 5-nitroimidazole antibiotic for the treatment of bacterial vaginosis Pharmacol Res Perspect. 2020 Aug;8(4):e00634. doi: 10.1002/prp2.634.
|
2 |
Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis Drugs. 1996 Apr;51(4):621-38. doi: 10.2165/00003495-199651040-00007.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.